Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Kinnate Biopharma Inc. KNTE

Full chart Compare
Set alert

Price alert · KNTE

All alert types
2.65 +2.65

Day range unavailable

52-week range unavailable

Financial health

Altman Z-Score

0.96 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

2 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

Valuation

P/E -1.0×
FY 2018: -217×FY 2019: -139×FY 2020: -49.1×FY 2021: -8.6×FY 2022: -2.4×FY 2023: -1.0×
FY 2018 5y median -8.6× FY 2023
P/S 0.0×
FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×
FY 2018 5y median 0.0× FY 2023
P/B 0.7×
FY 2018: 222×FY 2019: -96.7×FY 2020: 4.4×FY 2021: 2.4×FY 2022: 1.2×FY 2023: 0.7×
FY 2018 5y median 1.2× FY 2023
P/FCF -1.1×
FY 2018: -206×FY 2019: -161×FY 2020: -56.7×FY 2021: -10.8×FY 2022: -2.9×FY 2023: -1.1×
FY 2018 5y median -10.8× FY 2023
EV/EBITDA -0.5×
FY 2018: 220716×FY 2019: 134416×FY 2020: -38.0×FY 2021: -7.3×FY 2022: -2.1×FY 2023: -0.5×
FY 2018 5y median -2.1× FY 2023
EV/Sales 0.0×
FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×
FY 2018 5y median 0.0× FY 2023
FCF Yield -90.6%
FY 2018: -0.5%FY 2019: -0.6%FY 2020: -1.8%FY 2021: -9.3%FY 2022: -34.1%FY 2023: -90.6%
FY 2018 5y median -9.3% FY 2023

Profitability

Gross Margin 0.0%
FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%
FY 2018 5y median 0.0% FY 2023
Operating Margin 0.0%
FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%
FY 2018 5y median 0.0% FY 2023
Net Margin 0.0%
FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%
FY 2018 5y median 0.0% FY 2023
ROE -70.7%
FY 2018: -100.3%FY 2019: 68.2%FY 2020: -9.0%FY 2021: -28.0%FY 2022: -51.0%FY 2023: -70.7%
FY 2018 5y median -28.0% FY 2023
ROIC -73.2%
FY 2018: -100.3%FY 2019: -15.8%FY 2020: -9.2%FY 2021: -25.4%FY 2022: -45.1%FY 2023: -73.2%
FY 2018 5y median -25.4% FY 2023
ROA -64.9%
FY 2018: -94.5%FY 2019: -15.4%FY 2020: -8.8%FY 2021: -24.4%FY 2022: -40.9%FY 2023: -64.9%
FY 2018 5y median -24.4% FY 2023

Growth (YoY)

Revenue 0.0%
FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%
FY 2018 FY 2023
Operating Income -0.4%
FY 2018: 0.0%FY 2019: -57.4%FY 2020: -199.7%FY 2021: -150.3%FY 2022: -31.5%FY 2023: -0.4%
FY 2018 FY 2023
EPS (diluted) 6.6%
FY 2018: 0.0%FY 2019: -55.6%FY 2020: -189.3%FY 2021: -153.1%FY 2022: -26.3%FY 2023: 6.6%
FY 2018 FY 2023
Free Cash Flow -9.0%
FY 2018: 0.0%FY 2019: -28.3%FY 2020: -189.5%FY 2021: -135.7%FY 2022: -27.7%FY 2023: -9.0%
FY 2018 FY 2023

Financial Health

Current Ratio 13.2×
FY 2018: 17.3×FY 2019: 39.8×FY 2020: 54.8×FY 2021: 20.9×FY 2022: 13.4×FY 2023: 13.2×
FY 2018 5y median 20.9× FY 2023
Quick Ratio 13.2×
FY 2018: 17.3×FY 2019: 39.8×FY 2020: 54.8×FY 2021: 20.9×FY 2022: 13.4×FY 2023: 13.2×
FY 2018 5y median 20.9× FY 2023
Debt / Equity 0.0×
FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×
FY 2018 5y median 0.0× FY 2023
Net Debt / EBITDA 0.5×
FY 2018: -917×FY 2019: -6365×FY 2020: 10.2×FY 2021: 1.3×FY 2022: 0.2×FY 2023: 0.5×
FY 2018 5y median 0.5× FY 2023
Interest Coverage 0.0×
FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×
FY 2018 5y median 0.0× FY 2023

Dividends

Dividend Yield 0.0%
FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%
FY 2018 5y median 0.0% FY 2023
Payout Ratio 0.0%
FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%
FY 2018 5y median 0.0% FY 2023

Annual · latest fiscal year ends 2023-12-31